Nephrocare Health Services Limited (NSE:NEPHROPLUS)
India · Delayed Price · Currency is INR 528.60
+0.30 (0.06%)
At close: Apr 2, 2026
NSE:NEPHROPLUS Revenue
Nephrocare Health Services had revenue of 2.60B INR in the quarter ending December 31, 2025. This brings the company's revenue in the last twelve months to 9.52B. In the fiscal year ending March 31, 2025, Nephrocare Health Services had annual revenue of 7.56B with 33.50% growth.
Revenue (ttm)
9.52B
Revenue Growth
+33.50%
P/S Ratio
5.57
Revenue / Employee
2.76M
Employees
3,448
Market Cap
53.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 7.56B | 1.90B | 33.50% |
| Mar 31, 2024 | 5.66B | 1.29B | 29.47% |
| Mar 31, 2023 | 4.37B | 1.20B | 37.99% |
| Mar 31, 2022 | 3.17B | 324.38M | 11.40% |
| Mar 31, 2021 | 2.84B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tanla Platforms | 42.65B |
| Sheela Foam | 36.20B |
| DCB Bank | 29.05B |
| Fiem Industries | 26.82B |
| Wakefit Innovations | 14.48B |
| RateGain Travel Technologies | 13.69B |
| Mishra Dhatu Nigam | 10.66B |
| MAS Financial Services | 9.28B |